Ten Years Later: Jesse Gelsinger’s Death and Human Subjects Protection
By Osagie K. Obasogie, Bioethics Forum | 10. 22. 2009
Last month marked the tenth anniversary of Jesse Gelsinger's death. While perhaps not quite a household name, Gelsinger is vividly remembered among many medical researchers. His death during a gene therapy clinical trial in September 1999 rocked the field like nothing else since the Tuskegee experiments. But sadly, the questionable research practices that led to Gelsinger's death have only become more troublesome in the past decade. Indeed, protections for clinical trial participants seem to be waning at the very moment they are needed most.
Gelsinger suffered from orinthine trascarbamlase deficiency (OTCD), a rare metabolic disorder that prevents the body from breaking down ammonia. Many children with OTCD die at a young age, but Gelsinger had a mild version and led a fairly normal life through medicine and a special diet. Since a single-gene defect is responsible for OTCD, researchers considered it a prime candidate for gene therapy, a still-experimental treatment that attempts to replace defective genes with normal ones.
Gene therapy was the embryonic stem cell research of the 1990s; its ability to cure was thought to be boundless and...
Related Articles
By Travis Chi Wing Lau , Somatosphere [review of the book edited by CGS' Osagie K Obasogie and Marcy Darnovsky] | 09.13.2018
“The science will let loose its cascading interactions with utter impassivity; yet how we inhabit that knowledge will be a contest of the imagination, a sedimentation of political futures, a constructed infinity of worlds.” —Patricia J. Williams
What are...
When considering whether and how to proceed with regulating human germline gene editing, everyone supports public engagement. The National Academies of Sciences, Engineering, and Medicine (NAS), the Nuffield Council on Bioethics, and the Center for Genetics and Society (CGS) all recommend a robust public debate. But no one really knows how to conduct one, and all too many efforts lay a heavy hand on one of the scales.
The first step would seem to involve asking and answering the superficially...
By Hannah Devlin, The Guardian | 10.08.2018
People from minority ethnic backgrounds are set to lose out on medical benefits of genetics research due to an overwhelming bias towards studying white European populations, a leading scientist has warned.
Prof David Curtis, a geneticist and psychiatrist at University...
By Rob Stein, National Public Radio | 09.20.2018
Scientists say they have taken a potentially important — and possibly controversial — step toward creating human eggs in a lab dish.
A team of Japanese scientists turned human blood cells into stem cells, which they then transformed into very...
